Patents by Inventor Caleb GONZALEZ

Caleb GONZALEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230022045
    Abstract: Combination therapies for the treatment of cancers are provided. In some embodiments, a flagellin derivative such as CBLB502 is administered in combination with an immune checkpoint therapy (e.g., an anti-PD 1 antibody and an anti-CTLA4 antibody) to treat a cancer in a mammalian subject. In some embodiments, the combination therapy is administered intratumorally or peritumorally.
    Type: Application
    Filed: December 3, 2020
    Publication date: January 26, 2023
    Applicant: Board of Regents, The University of Texas System
    Inventors: David PIWNICA-WORMS, Caleb GONZALEZ, Seth GAMMON